An enzyme immunoassay for serum tobramycin

Clinica Chimica Acta; International Journal of Clinical Chemistry
G KominamiM Kono

Abstract

A heterogeneous enzyme immunoassay for serum tobramycin was developed using tobramycin-beta-D-galactosidase conjugate as the labelled antigen and 4-methylumbelliferyl-beta-D-galactoside as the fluorescence substrate. B/F separation was carried out using an immobilized second antibody, Immunobead. The minimal detectable level was 10 pg/tube or 0.2 microgram/ml of serum. Assay recovery was excellent and the intra-assay and inter-assay variances were 4.41% and 12.6%, respectively. The values from the enzyme immunoassay agreed well with those from radioimmunoassay and bioassay. This assay system is highly sensitive and can be easily applied to other drugs and hormones.

References

Oct 1, 1976·Antimicrobial Agents and Chemotherapy·A BroughtonG P Bodney
Oct 18, 1972·Nature: New Biology·J E LewisH A Elder
May 9, 1980·Clinica Chimica Acta; International Journal of Clinical Chemistry·G KominamiM Kono
Mar 1, 1981·Steroids·G KominamiM Kono

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.